3rd Annual World Ovarian Cancer Coalition Impact Award Recipients Announced

Share this page

Toronto, Ontario, December 1, 2023 – With a formal ceremony set to take place today, December 1, 2023, the World Ovarian Cancer Coalition released the names of this year’s recipients of the third annual World Ovarian Cancer Coalition Impact Awards.

Awards in 6 categories will be presented at the final session of the Coalition’s 3rd Annual Virtual Global Partner Meeting, being held at 2:00pm UTC. The winners, by category, are:

Inspiring Collaborations Award – this Award celebrates the remarkable achievements of people and organisations who have worked in partnership to make a difference. Recipients for this year are:

  • STAAR Ovarian Cancer, USA
  • Professor Ulla Puistola, Finland
  • Ovarian Cancer Research Foundation, Australia

The Every Woman Study™ Award – this Award is to recognize those that are demonstrating their use of The Every Woman Study™ to drive positive change for women within their own settings or country. The 2023 award this year goes to:

  • All clinical and patient advocacy leads of the Every Woman Study™: Low- and Middle-Income Edition, as well as the Study’s Oversight Committee

Transformational Researcher Award – this Award recognises those that have played a significant role in research into ovarian cancer. The 2023 award this year goes to:

  • Hayley Russell, Ovarian Cancer Australia, Australia

Above and Beyond Award – this new Award recognizes individuals or organizations who have gone beyond for those impacted by ovarian cancer, through exemplary care, dedication, and compassion. Recipients for this year are:

  • Acto Piemonte and RiDo – Ricerca per la Donna, Italy
  • Professor Donal Brennan, Ireland
  • Susan Hess, USA

World Ovarian Cancer Day Award – this category acknowledges an exceptional contribution to the annual World Ovarian Cancer Day Campaign and raising awareness of the disease locally, nationally, or internationally. Recipients for this year are:

  • ACCO and Fernando de Lima, Brazil
  • MOG, Portugal

Outstanding Achievement Award – this final award recognizes the exceptional achievement of an individual or organization who has significantly impacted the ovarian cancer community through their work. The recipient of this well-deserved award is:

  • Bar Levy, HaBait Shel Bar, Israel

Clara MacKay, CEO of the World Ovarian Cancer Coalition said: “With cases set to rise by almost 42% by 2040, the work of advocates who work on behalf of all of those impacted by ovarian cancer is more important than ever. It is truly humbling to see such incredible work achieved over the last year by all of our winners, nominees, and the wider ovarian cancer community. “

The awards ceremony will be streamed today, December 1st, at 2pm UTC during the World Ovarian Cancer Coalition Partner Meeting. More information on the meeting and awards ceremony, including replays of all sessions, can be found here: https://worldovariancancercoalition.org/2023-partner-meeting/

About the World Ovarian Cancer Coalition 

The World Ovarian Cancer Coalition is a not-for-profit organization, formally established in 2016, working across the globe towards a world where every woman with ovarian cancer has the best chance of survival, and the best quality of life – wherever she may live. More information can be found on www.worldovariancancercoalition.org

The Coalition is a network of close to 200 patient advocacy organizations in 51 countries around the world, building on the significant impact of the annual flagship ovarian cancer awareness campaign – World Ovarian Cancer Day, started in 2013 and the ground-breaking Every Woman Study™ published in 2018.  Building on the Study, the Coalition launched the Global Ovarian Cancer Charter at the International Gynecologic Cancer Society (IGCS) annual meeting in 2020. The Charter, a living document, pivots around six Global Goals and is a clear call-to-action for all those committed to improving survival and quality of life for women with ovarian cancer. In 2022 and in partnership with IGCS, the Coalition is undertaking the Every Woman Study™: Low- and Middle-Income Edition in over 25 countries, with initial results due late 2023.

For more information contact:

Phaedra Charlton (she/her)

Director of Communications and Marketing

worldovariancancercoalition.org

phaedra@worldovariancancercoalition.org